Vaccine Contract Manufacturing Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global vaccine contract manufacturing market is expected to grow at a CAGR of around 9.7% during 2023-2030. This report on global vaccine contract manufacturing market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global vaccine contract manufacturing market by segmenting the market based on process process type, vaccine type, scale of operation, service, application, end user and region. Also, detailed profiles of companies operating in the vaccine contract manufacturing market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
? Increasing Awareness
? Rising Demands of Generic Medication
? Increasing Demands of Cell and Gene Therapy
Market Challenges
? Outsourcing by Well-Established Vaccine Makers is Limited
Historical & Forecast Period
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Process Type
? Upstream
? Subunit Vaccines
? Live Attenuated Vaccines
? Conjugate Vaccines
? Inactivated Vaccines
? Recombinant Vector Vaccines
? Toxoid Vaccines
? Synthetic Vaccines
? Others
Market by Scale of Operation
? Commercial
? Pre-Clinical
? Clinical
Market by Service
? Bulk Product
? Fill Finish
Market by Application
? Human Use
? Veterinary
Market by End User
? Pharmaceutical Companies
? Biotech Companies
? Others
Market by Region
Market Drivers
? Increasing Awareness
? Rising Demands of Generic Medication
? Increasing Demands of Cell and Gene Therapy
Market Challenges
? Outsourcing by Well-Established Vaccine Makers is Limited
Historical & Forecast Period
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Process Type
? Upstream
- Mammalian Expression Systems
- Bacterial Expression Systems
- Yeast Expression Systems
- Baculovirus/Insect Expression Systems
- Others
- Fill and Finish Operations
- Analytical and QC studies
- Packaging
? Subunit Vaccines
? Live Attenuated Vaccines
? Conjugate Vaccines
? Inactivated Vaccines
? Recombinant Vector Vaccines
? Toxoid Vaccines
? Synthetic Vaccines
? Others
Market by Scale of Operation
? Commercial
? Pre-Clinical
? Clinical
Market by Service
? Bulk Product
? Fill Finish
Market by Application
? Human Use
? Veterinary
Market by End User
? Pharmaceutical Companies
? Biotech Companies
? Others
Market by Region
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Iran
- Rest of Middle East & Africa
1. PREFACE
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. KEY INSIGHTS
3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET ANALYSIS
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY PROCESS TYPE
5.1. Introduction
5.2. Upstream
5.3. Downstream
6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY VACCINE TYPE
6.1. Introduction
6.2. Subunit Vaccines
6.3. Live Attenuated Vaccines
6.4. Conjugate Vaccines
6.5. Inactivated Vaccines
6.6. Recombinant Vector Vaccines
6.7. Toxoid Vaccines
6.8. Synthetic Vaccines
6.9. Others
7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION
7.1. Introduction
7.2. Commercial
7.3. Pre-Clinical
7.4. Clinical
8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY SERVICE
8.1. Introduction
8.2. Bulk Product
8.3. Fill Finish
9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY APPLICATION
9.1. Introduction
9.2. Human Use
9.3. Veterinary
10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY END USER
10.1. Introduction
10.2. Pharmaceutical Companies
10.3. Biotech Companies
10.4. Others
11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY REGION
11.1. Introduction
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Netherlands
11.2.8. Rest of the Europe
11.3. North America
11.3.1. United States
11.3.2. Canada
11.4. Asia Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. South Korea
11.4.5. Australia
11.4.6. Indonesia
11.4.7. Rest of the Asia Pacific
11.5. Latin America
11.5.1. Mexico
11.5.2. Brazil
11.5.3. Argentina
11.5.4. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. Turkey
11.6.3. Iran
11.6.4. United Arab Emirates
11.6.5. Rest of Middle East & Africa
12. SWOT ANALYSIS
13. PORTER’S FIVE FORCES
14. MARKET VALUE CHAIN ANALYSIS
15. COMPETITIVE LANDSCAPE
15.1. Competitive Scenario
15.2. Company Profiles
15.2.1. Albany Molecular Research Inc
15.2.2. Merck KGaA
15.2.3. Ajinomoto Co. Inc
15.2.4. Boehringer Ingelheim
15.2.5. Catalent Inc
15.2.6. Cobra Biologics Limited (Charles River Laboratories International Inc.)
15.2.7. Cytovance Biologics Inc. (Hepalink USA Inc.)
15.2.8. Fujifilm Holdings Corporation
15.2.9. GlaxoSmithKline
15.2.10. ICON plc
15.2.11. IDT Biologika GmbH
15.2.12. Lonza Group AG
15.2.13. Merck KGaA
15.2.14. Pfizer
15.2.15. Pharmaceutical Product Development LLC
15.2.16. PRA Health Sciences Inc.
15.2.17. Recipharm
15.2.18. Serum Institute of India
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. KEY INSIGHTS
3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET ANALYSIS
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY PROCESS TYPE
5.1. Introduction
5.2. Upstream
5.3. Downstream
6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY VACCINE TYPE
6.1. Introduction
6.2. Subunit Vaccines
6.3. Live Attenuated Vaccines
6.4. Conjugate Vaccines
6.5. Inactivated Vaccines
6.6. Recombinant Vector Vaccines
6.7. Toxoid Vaccines
6.8. Synthetic Vaccines
6.9. Others
7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION
7.1. Introduction
7.2. Commercial
7.3. Pre-Clinical
7.4. Clinical
8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY SERVICE
8.1. Introduction
8.2. Bulk Product
8.3. Fill Finish
9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY APPLICATION
9.1. Introduction
9.2. Human Use
9.3. Veterinary
10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY END USER
10.1. Introduction
10.2. Pharmaceutical Companies
10.3. Biotech Companies
10.4. Others
11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET BY REGION
11.1. Introduction
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Netherlands
11.2.8. Rest of the Europe
11.3. North America
11.3.1. United States
11.3.2. Canada
11.4. Asia Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. South Korea
11.4.5. Australia
11.4.6. Indonesia
11.4.7. Rest of the Asia Pacific
11.5. Latin America
11.5.1. Mexico
11.5.2. Brazil
11.5.3. Argentina
11.5.4. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. Turkey
11.6.3. Iran
11.6.4. United Arab Emirates
11.6.5. Rest of Middle East & Africa
12. SWOT ANALYSIS
13. PORTER’S FIVE FORCES
14. MARKET VALUE CHAIN ANALYSIS
15. COMPETITIVE LANDSCAPE
15.1. Competitive Scenario
15.2. Company Profiles
15.2.1. Albany Molecular Research Inc
15.2.2. Merck KGaA
15.2.3. Ajinomoto Co. Inc
15.2.4. Boehringer Ingelheim
15.2.5. Catalent Inc
15.2.6. Cobra Biologics Limited (Charles River Laboratories International Inc.)
15.2.7. Cytovance Biologics Inc. (Hepalink USA Inc.)
15.2.8. Fujifilm Holdings Corporation
15.2.9. GlaxoSmithKline
15.2.10. ICON plc
15.2.11. IDT Biologika GmbH
15.2.12. Lonza Group AG
15.2.13. Merck KGaA
15.2.14. Pfizer
15.2.15. Pharmaceutical Product Development LLC
15.2.16. PRA Health Sciences Inc.
15.2.17. Recipharm
15.2.18. Serum Institute of India
LIST OF TABLES
Table 1: Global Vaccine Contract Manufacturing Market Portraiture
Table 2: Global Vaccine Contract Manufacturing Market by Process Type (in US$ Million), 2022 & 2030
Table 3: Global Vaccine Contract Manufacturing Market by Vaccine Type (in US$ Million), 2022 & 2030
Table 4: Global Vaccine Contract Manufacturing Market by Scale of Operation (in US$ Million), 2022 & 2030
Table 5: Global Vaccine Contract Manufacturing Market by Service (in US$ Million), 2022 & 2030
Table 6: Global Vaccine Contract Manufacturing Market by Application (in US$ Million), 2022 & 2030
Table 7: Global Vaccine Contract Manufacturing Market by End User (in US$ Million), 2022 & 2030
Table 8: Global Vaccine Contract Manufacturing Market by Region (in US$ Million), 2022 & 2030
Table 9: Europe Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 10: North America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 11: Asia Pacific Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 12: Latin America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 13: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 14: List of Key Players
Table 1: Global Vaccine Contract Manufacturing Market Portraiture
Table 2: Global Vaccine Contract Manufacturing Market by Process Type (in US$ Million), 2022 & 2030
Table 3: Global Vaccine Contract Manufacturing Market by Vaccine Type (in US$ Million), 2022 & 2030
Table 4: Global Vaccine Contract Manufacturing Market by Scale of Operation (in US$ Million), 2022 & 2030
Table 5: Global Vaccine Contract Manufacturing Market by Service (in US$ Million), 2022 & 2030
Table 6: Global Vaccine Contract Manufacturing Market by Application (in US$ Million), 2022 & 2030
Table 7: Global Vaccine Contract Manufacturing Market by End User (in US$ Million), 2022 & 2030
Table 8: Global Vaccine Contract Manufacturing Market by Region (in US$ Million), 2022 & 2030
Table 9: Europe Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 10: North America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 11: Asia Pacific Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 12: Latin America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 13: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in US$ Million), 2022 & 2030
Table 14: List of Key Players
LIST OF FIGURES
Figure 1: Global Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 2: Global Vaccine Contract Manufacturing Market by Process Type, 2022
Figure 3: Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022
Figure 4: Global Vaccine Contract Manufacturing Market by Scale of Operation, 2022
Figure 5: Global Vaccine Contract Manufacturing Market by Service, 2022
Figure 6: Global Vaccine Contract Manufacturing Market by Application, 2022
Figure 7: Global Vaccine Contract Manufacturing Market by End User, 2022
Figure 8: Global Vaccine Contract Manufacturing Market by Region, 2022
Figure 9: Global Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 10: Global Vaccine Contract Manufacturing Market by Process Type (in %), 2022 & 2030
Figure 11: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 12: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 13: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 14: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 15: Global Vaccine Contract Manufacturing Market by Vaccine Type (in %), 2022 & 2030
Figure 16: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 17: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 18: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 19: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 20: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 21: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 22: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 23: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 24: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 25: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 26: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 27: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 28: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 29: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 30: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 31: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 32: Global Vaccine Contract Manufacturing Market by Scale of Operation (in %), 2022 & 2030
Figure 33: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 34: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 35: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 36: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 37: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 38: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 39: Global Vaccine Contract Manufacturing Market by Service (in %), 2022 & 2030
Figure 40: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 41: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 42: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 43: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 44: Global Vaccine Contract Manufacturing Market by Application (in %), 2022 & 2030
Figure 45: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 46: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 47: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 48: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 49: Global Vaccine Contract Manufacturing Market by End User (in %), 2022 & 2030
Figure 50: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 51: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 52: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 53: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 54: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 55: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 56: Global Vaccine Contract Manufacturing Market by Region (in %), 2022 & 2030
Figure 57: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 58: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 59: Europe Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 60: Germany Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 61: United Kingdom Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 62: France Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 63: Italy Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 64: Spain Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 65: Russia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 66: Netherlands Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 67: North America Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 68: North America Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 69: North America Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 70: United States Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 71: Canada Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 72: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 73: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 74: Asia Pacific Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 75: China Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 76: Japan Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 77: India Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 78: South Korea Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 79: Australia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 80: Indonesia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 81: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 82: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 83: Latin America Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 84: Mexico Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 85: Brazil Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 86: Argentina Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 87: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 88: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 89: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 90: Saudi Arabia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 91: Turkey Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 92: Iran Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 93: UAE Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 94: Rest of Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 95: Market Value Chain
Figure 1: Global Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 2: Global Vaccine Contract Manufacturing Market by Process Type, 2022
Figure 3: Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022
Figure 4: Global Vaccine Contract Manufacturing Market by Scale of Operation, 2022
Figure 5: Global Vaccine Contract Manufacturing Market by Service, 2022
Figure 6: Global Vaccine Contract Manufacturing Market by Application, 2022
Figure 7: Global Vaccine Contract Manufacturing Market by End User, 2022
Figure 8: Global Vaccine Contract Manufacturing Market by Region, 2022
Figure 9: Global Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 10: Global Vaccine Contract Manufacturing Market by Process Type (in %), 2022 & 2030
Figure 11: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 12: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 13: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 14: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 15: Global Vaccine Contract Manufacturing Market by Vaccine Type (in %), 2022 & 2030
Figure 16: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 17: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 18: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 19: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 20: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 21: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 22: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 23: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 24: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 25: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 26: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 27: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 28: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 29: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 30: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 31: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 32: Global Vaccine Contract Manufacturing Market by Scale of Operation (in %), 2022 & 2030
Figure 33: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 34: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 35: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 36: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 37: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 38: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 39: Global Vaccine Contract Manufacturing Market by Service (in %), 2022 & 2030
Figure 40: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 41: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 42: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 43: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 44: Global Vaccine Contract Manufacturing Market by Application (in %), 2022 & 2030
Figure 45: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 46: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 47: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 48: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 49: Global Vaccine Contract Manufacturing Market by End User (in %), 2022 & 2030
Figure 50: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 51: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 52: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 53: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 54: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 55: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 56: Global Vaccine Contract Manufacturing Market by Region (in %), 2022 & 2030
Figure 57: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 58: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 59: Europe Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 60: Germany Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 61: United Kingdom Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 62: France Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 63: Italy Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 64: Spain Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 65: Russia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 66: Netherlands Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 67: North America Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 68: North America Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 69: North America Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 70: United States Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 71: Canada Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 72: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 73: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 74: Asia Pacific Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 75: China Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 76: Japan Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 77: India Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 78: South Korea Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 79: Australia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 80: Indonesia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 81: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 82: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 83: Latin America Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 84: Mexico Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 85: Brazil Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 86: Argentina Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 87: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2018-2022
Figure 88: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2023-2030
Figure 89: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in %), 2022 & 2030
Figure 90: Saudi Arabia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 91: Turkey Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 92: Iran Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 93: UAE Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 94: Rest of Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 95: Market Value Chain
